Brian O Mahony/X
Jun 24, 2025, 22:08
Rewriting Your DNA in Childhood: Because Why Wait to Cure Hemophilia? | ISTH 2025 Breakthrough
Ben Samelson-Jones, Assistant Professor of Pediatrics at University of Pennsylvania School of Medicine, posted on X:
”Sustained and stable FIX levels have now been repeatedly been observed across multiple #genetherapy clinical trials for Hemophila B. Will extend the red line tomorrow at Clinical Gene Therapy session at ISTH2025.”
Reposting from Brian O Mahony, CEO of the Irish Haemophilia Society and former President of both the WFH and EHC, sharing bold new advances in haemophilia management presented at ISTH 2025 via X:
”FIX expression and durability compared between clinical trials. Malec, ISTH2025.”
Gene Editing: Welcome to a New World!
A shot and you are done with Hemophilia B?
Don’t miss the new updates with Hemostasis Today.
-
Apr 10, 2026, 18:22Chris Hillis: Reflections on My Term as President of the Canadian Hematology Society
-
Apr 10, 2026, 17:59Michelle Leona Cecil: Representing Microhealth at The Coalition for Hemophilia B Annual Symposium
-
Apr 10, 2026, 17:47Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
-
Apr 10, 2026, 17:39Diverse Voices But Shared Mission – Day 1 of EHC Youth Leadership Workshop
-
Apr 10, 2026, 17:30Make Your Mark at the World Stroke Congress 2026 – World Stroke Organization
-
Apr 10, 2026, 17:23Sofie Abels: Implications for Targeted Screening for Thrombophilia in Young Stroke Patients
-
Apr 10, 2026, 17:08Armghan Ans: 3 Questions Worth Sitting with If You Work in Stroke AI
-
Apr 10, 2026, 17:03William Wallace: Vitamin C Is More Than ”Immune Support”
-
Apr 10, 2026, 16:58Wolfgang Miesbach: Greater Symptom Burden in Women with Bleeding Disorders – Insights from Irish Data